Article
A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.
Familial cancer - 1 Apr 2023
McVeigh Terri Patricia, Sweeney Karl J, Brennan Donal J, McVeigh Una M, Ward Simon, Strydom Ann, Seal Sheila, Astbury Katherine, Donnellan Paul, Higgins Joanne, Keane Maccon, Kerin Michael J, Malone Carmel, McGough Pauline, McLaughlin Ray, O'Leary Michael, Rushe Margaret, Barry Michael Kevin, MacGregor Geraldine, Sugrue Michael, Yousif Ala, Al-Azawi Dhafir, Berkeley Eileen, Boyle Terence J, Connolly Elizabeth M, Nolan Carmel, Richardson Elaine, Giffney Claire, Doyle Samantha B, Broderick Sheila, Boyd William, McVey Ruaidhri, Walsh Thomas, Farrell Michael, Gallagher David J, Rahman Nazneen, George Angela J
Abstract excerpt
In the Republic of Ireland (ROI), BRCA1/BRCA2 genetic testing has been traditionally undertaken in eligible individuals, after pre-test counselling by a Clinical Geneticist/Genetic Counsellor. Clinical Genetics services in ROI are poorly resourced, with routine waiting times for appointments at the time of this pilot often extending beyond a year. The consequent prolonged waiting times are unacceptable where...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.